dibenzo-p-dioxin alters rat hypothalamic endorphin and rau opioid receptors. NEUROTOXICOL TERATOL 13(5) 495--497, 1991.--The present study was undertaken to assess ff hypothalamic 13-endorphin (13E) and/or brain mu opioid receptors are associated with 2, 3, 7, 8-tenachiorodibenzo-p-dioxin (TCDD) (50 p.g/kg)-induced hypophagia and body weight decline in rats. Hypothaiamic IBE concentrations were initially increased to 166% of controls on day 1, and then were depressed to 39% and 49% of control values on days 2 and 3, respectively. Brain rnu opioid receptor number was increased 60% in TCDD-treated rats at day 3 without a change in the binding affinity. Food-restricted rats did not exhibit changes in hypothaiamic IBE concentrations or brain mu opioid receptor number. These results indicate that TCDD causes early perturbations in hypothaiamic IBE concentrations and brain mu receptor number, which may contribute to the mechanisms by which TCDD leads to decreased food intake and progressive weight loss.
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2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin
Hypothaiamic IB-endorphin Brain mu opioid receptor Food intake TCDD is an undesired by-product produced during the synthesis of various chlorinated phenolic compounds, incineration of waste, and bleaching of paper pulp. There is considerable concern of potential health hazards associated with the release of this substance into the environment. Animals exposed to a single, oral dose of TCDD typically begin to exhibit reduced food intake after two to three days that is associated with progressive weight loss, and mobilization of adipose tissue stores (5, 7, 9) . Furthermore, loss of appetite and decreased body weight have been reported in humans exposed to TCDD in the work place (16, 17, 19) . The TCDD induced anorexia may be due to a specific effect on the regulatory systems of food intake. The regulation of food intake and appetite is an extremely complex process which involves numerous peptides and hormones (10, 12) . The hypothalamus has been considered to play a central role in this regulation (11) . The hypothalamus maintains the nutritional homeostasis of the organism by activating or deactivating the food-seeking behaviors of the animal. It is known that endogenous opioid peptides (EOP) such as 13E play a physiological role in appetite and regulation of food intake (2, 6, 13) . Different areas of the hypothalamus have been associated with EOP mediated modulation of eating. The hypothalamus, like the pituitary, contains proopiomelanocortin (POMC), the precursor molecule for the opioid 13E. 13E, a by-product of the precursor POMC peptide, is present in high concentrations in the hypothalamus (10) . It has been suggested that decreased hypothalamic 13E concentration is a mechanism for the down regulation of feeding behavior to conserve energy during periodic food shortages (4). It has also been shown that opioid receptor receptor blockade (i.e., antagonist binding) reduces food intake and body weight (2, 6, 13). The possibility exists that TCDD intoxication may affect levels of EOP and their receptors, which could have a profound impact on the regulation of feeding behavior. Thus this study was performed to assess if hypothalamic 13E and its brain receptor (mu) are associated with TCDD-induced anorexia and body weight decline.
METHOD TCDD (50 p,g/kg) was administered in a single, oral dose to adult, male Sprague-Dawley rats (200--220g). This is a dose less than the reported LDso for adult, male Sprague-Dawley rats (60 1Requests for reprints should be addressed to Waiter N. Piper at his current address: Toxicology Program, University of Michigan, 109 S. Observatory, 6108 SPH-II, Ann Arbor, MI 48109-2029.
BESTERVELT ET AL. p,g/kg) (1). However, it is important to note that in this strain of rats in our laboratory, a 50 ~g/kg oral dose of TCDD has never produced deaths at three weeks of exposure. Acetone-corn oil (1:2; 3.8 ml/kg), served as the control vehicle. Rats were permitted food and water ad lib. A weight-matched group of rats had their food restricted. At early time periods of 1-3 days, it is not practical to employ paired-feeding studies since they comprise providing food amounts consumed the previous day. Therefore, food-restricted rats were given the amount of food consumed from previous experiments in which 30 rats of the same weight range were administered the same dose of TCDD (50 p,g/kg; single oral dose). These restricted amounts of food were 3, 6, and 6 grams at days 1, 2, and 3, respectively. This was done to confirm that the effects of treatment were due to TCDD and not to a decrease in food intake. All animals were maintained on a controlled light cycle (6:00 a.m. lights on; 6:00 p.m. lights off), with restricted access to minimize environmental disturbances to the rats for the duration of the experiment. Rats were killed (9:00 a.m.) by decapitation, their brains rapidly removed, and hypothalamic blocks dissected with the following limits: cuts were made posterior to the optic chiasm, anterior to the mamillary bodies and through the lateral hypothalamic sulci, with a depth of 2 mm. The hypothalami were frozen in liquid nitrogen, lyophilized and extracted in 0.1 N HC1 (15) . Hypothalamic extracts were analyzed for 13E content using a radioimmunoassay kit obtained from INCSTAR (Stillwater, MN). The sensitivity of the assay was 10 pg/ml. The data were statistically evaluated by analysis of variance 09<0.05) with differences between means evaluated by Tukey's Test (,o<0.05).
Membranes from rat cerebrum were prepared and mu opioid receptor binding assays were performed (3). The binding-assay reaction consisted of 190 I~1 of membrane suspension (approximately 0.6 mg/ml protein), 20 ixl of distilled H20, 25 Ixl of either distilled H20 or excess (2 v,M) [D-Ala 2, NMe-Pbe 4, Glyol]-Enkephalin (DAGO), and 25 Ixl of the appropriate concentration of SH-DAGO (0.125-10 nM) in 8 ml polypropylene tubes. The final volume of the assay was 260 I~l. Specific binding of the radioligand is defined as the difference between binding in the absence and presence of an appropriate excess of DAGO. After incubation for 80 minutes at 25°C (reflecting binding equilibrium), the samples were filtered through glass fiber filters (GF/ C). The filtered samples were washed with ice cold 50 mM Tris-HC1, pH 7.4, and placed into polyethylene counting vials. After addition of 1 ml absolute ethanol followed by 10 ml of biodegradable scintillation fluid, vials were subjected to liquid scintillation counting. Receptor number (Bronx) and binding affinity (Kd) were determined by Scatchard analysis (18) . Protein concentration was determined by the method of Lowry and coworkers (8) . The data were statistically evaluated by analysis of variance (p<0.05) with differences between means evaluated by Tukey's Test (p<0.05).
RESULTS
Body weights did not differ at days 1 and 2 for control, food-restricted control or TCDD groups. At day 3, body weights of TCDD-treated animals (196__ + _ 5) were significantly lower than control (223--.4) or food-restricted control (220+-.6) groups, which did not differ from each other. Rat hypothalamic 13E concentrations were initially found to be significantly higher than controls at day 1, and then were significantly depressed at days 2 and 3 following the administration of TCDD (Fig. 1) . Hypothalamic I~E levels were increased to 166% of controls on day I; whereas at days 2 and 3 hypothalamic 13E concentrations were depressed to 39% and 49% of control values, respectively. Restricting the food intake did not change hypothalamic [3E con- centration at day 3 (11.6+--1.9 and 12.3+__1.7 for control and food-restricted control groups, respectively: p>0.05). The receptor for 13E (mu) was then analyzed after TCDD treatment by Scatchard analysis. Brain mu receptor number (Bm~,) at day 3 was increased 60% over control values following administration of TCDD, but the binding affinity (Ka) of the mu receptor remained unchanged. Restricting the food intake did not change either brain mu receptor number or affinity (Table 1 ). Figure 2 shows a typical Scatchard plot of the specific binding of DAGO in control and TCDD-treated rats. Table 1 . The r value was greater than .940 in all cases. Rats were treated with a single, oral dose of TCDD (50 p.g/kg) and sacrificed at day 3.
Values represent the mean _+ SEM for 4 rats. *Denotes a significant difference (p<0.05) between control and treated rats.
DISCUSSION
It is known that EOP are involved in the highly complex chain of events forming the biochemical basis of appetite and regulation of food intake. It has been suggested that a decrease in hypothalamic 13E levels is a mechanism for the down regulation of feeding behavior to conserve energy during periodic food shortages (4). It has also been shown that opioid receptor antagonists reduce food intake and body weight by displacement of opioid peptides at their binding site (2, 6, 13) . A characteristic of antagonist treatment is an upregulation of the opioid receptor (14, 20--22) . Since the present study shows that TCDD causes an increase in receptor number, it appears that TCDD may be acting as an opioid antagonist. This change, along with the decrease in hypothalamic 13E levels, is coincident with the time interval that rats begin to exhibit reduced-food intake and progressive weight loss after exposure to TCDD. In addition, rats receiving an amount of food comparable to that consumed by TCDD-treated rats had 13E and mu receptor numbers similar to control rats. These results demonstrate discrete effects of TCDD which axe not due to a decrease in food consumption. Thus our data suggest that a mechanism by which TCDD exerts its effects on rat appetite regulation is two fold; first, by decreasing hypothalamic I3E levels and second, by displacement of 13E at the opioid receptor site. These data do not rule out the possible participation of biogenic amines, other neuropeptides or hormones in TCDD-induced hypophagia.
Conclusion
The present findings suggest that EOP may contribute to the mechanisms by which TCDD exposure leads to depressed food intake and progressive weight loss. This knowledge may ultimately lead to information enabling treatment regimens to restore feeding and correct body weight loss associated with exposure to this toxicant.
